Related references
Note: Only part of the references are listed.Statin Therapy and Outcome After Ischemic Stroke Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials
Danielle Ni Chroinin et al.
STROKE (2013)
Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials
Seung-Kwon Myung et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
Yu-Miao Wei et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus
Lin Zhang et al.
ATHEROSCLEROSIS (2012)
Subcellular Localization of Oxidants and Redox Modulation of Endothelial Nitric Oxide Synthase
Bradley A. Maron et al.
CIRCULATION JOURNAL (2012)
Statins and vein graft failure in coronary bypass surgery
Marios Margaritis et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Simvastatin Decreases Free Radicals Formation in the Human Abdominal Aortic Aneurysm Wall via NF-κB
A. Piechota-Polanczyk et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2012)
Actions of antioxidants in the protection against atherosclerosis
Maria E. Loenn et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Essential Role of MicroRNA-155 in Regulating Endothelium-Dependent Vasorelaxation by Targeting Endothelial Nitric Oxide Synthase
Hai-Xiang Sun et al.
HYPERTENSION (2012)
Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells
Chie Aoki et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Myocardial Redox State Predicts In-Hospital Clinical Outcome After Cardiac Surgery Effects of Short-Term Pre-Operative Statin Treatment
Charalambos Antoniades et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice
Ying Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Translating the effects of statins: From redox regulation to suppression of vascular wall inflammation
Alexios S. Antonopoulos et al.
THROMBOSIS AND HAEMOSTASIS (2012)
The effect of simvastatin on asymmetric dimethylarginine and flow-mediated vasodilation after optimizing the LDL level - A randomized, placebo-controlled study
Lyudmila G. Vladimirova-Kitova et al.
VASCULAR PHARMACOLOGY (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Endothelial Nox4 NADPH Oxidase Enhances Vasodilatation and Reduces Blood Pressure In Vivo
Robin Ray et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Differential metabolic effects of distinct statins
Kwang Kon Koh et al.
ATHEROSCLEROSIS (2011)
Crosstalk of reactive oxygen species and NF-kappa B signaling
Michael J. Morgan et al.
CELL RESEARCH (2011)
Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling
Charalambos Antoniades et al.
CIRCULATION (2011)
AHA/ACCF Secondary Prevention and Risk REduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 Update - A Guideline from the American Heart Association and American College of Cardiology Foundation
Sidney C. Smith et al.
CIRCULATION (2011)
Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries
Luciana V. Rossoni et al.
CLINICAL SCIENCE (2011)
Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients
Edward J. Mills et al.
EUROPEAN HEART JOURNAL (2011)
Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism
Yingzi Pei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide
Cristine Skogastierna et al.
HEART AND VESSELS (2011)
Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation
Ebru Demirel Sezer et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2011)
Atorvastatin Inhibits gp91phox Circulating Levels in Patients With Hypercholesterolemia
Pasquale Pignatelli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Induction of Endothelial Nitric Oxide Synthase, SIRT1, and Catalase by Statins Inhibits Endothelial Senescence Through the Akt Pathway
Hidetaka Ota et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway
Shin Makabe et al.
ATHEROSCLEROSIS (2010)
Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway
Dionysios Chartoumpekis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Atorvastatin Reduces Plaque Vulnerability in an Atherosclerotic Rabbit Model by Altering the 5-Lipoxygenase Pathway
Guangyi Zhou et al.
CARDIOLOGY (2010)
Preoperative Atorvastatin Treatment in CABG Patients Rapidly Improves Vein Graft Redox State by Inhibition of Rae1 and NADPH-Oxidase Activity
Charalambos Antoniades et al.
CIRCULATION (2010)
Therapeutic Targeting of Mitochondrial Superoxide in Hypertension
Anna E. Dikalova et al.
CIRCULATION RESEARCH (2010)
Evidence of Pre-Procedural Statin Therapy A Meta-Analysis of Randomized Trials
David E. Winchester et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Randomized Placebo-Controlled Trial Assessing a Treatment Strategy Consisting of Pravastatin, Vitamin E, and Homocysteine Lowering on Plasma Asymmetric Dimethylarginine Concentration in Mild to Moderate CKD
Prabath W. B. Nanayakkara et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: Results of the CEZAR study
Mir Abolfazl Ostad et al.
ATHEROSCLEROSIS (2009)
Evidence for Statin Pleiotropy in Humans Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation
Ping-Yen Liu et al.
CIRCULATION (2009)
Preoperative sCD40L Levels Predict Risk of Atrial Fibrillation After Off-Pump Coronary Artery Bypass Graft Surgery
Charalambos Antoniades et al.
CIRCULATION (2009)
Induction of Prostacyclin by Steady Laminar Shear Stress Suppresses Tumor Necrosis Factor-α Biosynthesis via Heme Oxygenase-1 in Human Endothelial Cells
Luigia Di Francesco et al.
CIRCULATION RESEARCH (2009)
Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis
Charalambos Antoniades et al.
EUROPEAN HEART JOURNAL (2009)
Atorvastatin Prevents Endothelial Dysfunction in Mesenteric Arteries From Spontaneously Hypertensive Rats Role of Cyclooxygenase 2-Derived Contracting Prostanoids
Agostino Virdis et al.
HYPERTENSION (2009)
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk
Rainer H. Boeger et al.
PHARMACOLOGICAL RESEARCH (2009)
Pleiotropic Effect of Lovastatin, With and Without Cholestyramine, in the Post Coronary Artery Bypass Graft (Post CABG) Trial
Michael Domanski et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Statin Adverse Effects A Review of the Literature and Evidence for a Mitochondrial Mechanism
Beatrice A. Golomb et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2008)
Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus
Philip Wenzel et al.
ATHEROSCLEROSIS (2008)
Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure
Joanna M. Young et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production
Sergey I. Dikalov et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats
Pierre Sicard et al.
FREE RADICAL RESEARCH (2008)
Temporal Gene Expression Analysis of Human Coronary Artery Endothelial Cells Treated With Simvastatin
LI QIN ZHANG et al.
GENE EXPRESSION (2008)
Short term fluvastatin treatment lowers serum asymmetric dimethylarginine levels in patients with metabolic syndrome
Aytekin Ocuz et al.
INTERNATIONAL HEART JOURNAL (2008)
Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme
Chun-An Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Calcium-Dependent NOX5 Nicotinamide Adenine Dinucleotide Phosphate Oxidase Contributes to Vascular Oxidative Stress in Human Coronary Artery Disease
Tomasz J. Guzik et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Statin Treatment and 3' Polyadenylation of eNOS mRNA
Ioanna Kosmidou et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials
Jonathan Afilalo et al.
HEART (2007)
Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin -: Effect of combination with oral L-arginine
Gerhild I. Boeger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells
Jun-Lin Jiang et al.
BIOCHEMISTRY AND CELL BIOLOGY (2007)
The effect of statin on the aortic gene expression profiling
Shu-Lin Liu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Nitric oxide and peroxynitrite in health and disease
Pal Pacher et al.
PHYSIOLOGICAL REVIEWS (2007)
Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke
Hua Hong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Simvastatin improves diabetes-induced coronary endothelial dysfunction
Huda E. Tawfik et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
Christopher P. Cannon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Endothelial protection, AT1 blockade and cholesterol-dependent oxidative stress -: The EPAS trial
Henning Morawietz et al.
CIRCULATION (2006)
Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-κB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin
Bysani Chandrasekar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Statins prevent NF-κB transactivation independently of the IKK-pathway in human endothelial cells
H Hölschermann et al.
ATHEROSCLEROSIS (2006)
Improvement of age-related endothelial dysfunction by simvastatin:: effect on NO and COX pathways
MA de Sotomayor et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Simvastatin versus ezetimibe -: Pleiotropic and lipid-lowering effects on endothelial function in humans
U Landmesser et al.
CIRCULATION (2005)
HMG-CoA reductase inhibitors reduce IκB kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells
M Ortego et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase - Differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin
AJ Cardounel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Fluvastatin inhibits the expression of tumor necrosis factor-α and activation of nuclear factor-κB in human endothelial cells stimulated by C-reactive protein
HR Wang et al.
CLINICA CHIMICA ACTA (2005)
Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: A role for glomeruli protection
B Zhu et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2005)
Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin
JR Jacobson et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Hydroxymethyl-glutaryl coenzyme A reductase inhibition limits cytomegalovirus infection in human endothelial cells
L Potena et al.
CIRCULATION (2004)
Simvastatin modulates TNFα-induced adhesion molecules expression in human endothelial cells
D Zapolska-Downar et al.
LIFE SCIENCES (2004)
Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with Hypercholesterolemia
TM Lu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Endothelial function - A critical determinant in atherosclerosis?
U Landmesser et al.
CIRCULATION (2004)
Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence
F Scalera et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells
RP Brandes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression
NJ Alp et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Effects of simastatin on endothelial function after chronic inhibition of nitric oxide synthase by L-NAME
C Pérez-Guerrero et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation
R Dechend et al.
CIRCULATION (2003)
Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits
H Mitani et al.
PHARMACOLOGY (2003)
Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo
M Pelat et al.
CIRCULATION (2003)
Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects
EC Pereira et al.
FREE RADICAL RESEARCH (2003)
Vascular smooth muscle cell activation by C-reactive protein
Y Hattori et al.
CARDIOVASCULAR RESEARCH (2003)
HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells
Y Hattori et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin
HM Eid et al.
ATHEROSCLEROSIS (2003)
Simvastatin reduces NF-kappa B activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet
MA Hernandez-Presa et al.
CARDIOVASCULAR RESEARCH (2003)
HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells
W Dichtl et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
The DDAH/ADMA/NOS pathway
CTL Tran et al.
ATHEROSCLEROSIS SUPPLEMENTS (2003)
Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events - Does statin treatment influence plasma ADMA levels?
VP Valkonen et al.
ATHEROSCLEROSIS SUPPLEMENTS (2003)
Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1
DY Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation -: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin
M Christ et al.
DIABETES (2002)
Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice
C Vecchione et al.
CIRCULATION RESEARCH (2002)
Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function - A prospective study
N Gokce et al.
CIRCULATION (2002)
Modulation of inflammatory mediators and PPARγ and NFκB expression by pravastatin in response to lipoproteins in human monocytes in vitro
I Zelvyte et al.
PHARMACOLOGICAL RESEARCH (2002)
Cellular antioxidant effects of atorvastatin in vitro and in vivo
S Wassmann et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins
A Brouet et al.
CIRCULATION RESEARCH (2001)
Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells - Antioxidative potential of hydroxymethylglutaryl coenzyme a reductase inhibitor therapy
U Rueckschloss et al.
CIRCULATION (2001)
Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
R Dechend et al.
CIRCULATION (2001)
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species
S Wassmann et al.
HYPERTENSION (2001)
Structural mechanism for statin inhibition of HMG-CoA reductase
ES Istvan et al.
SCIENCE (2001)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs -: Balance between transcriptional and posttranscriptional regulation
J Martínez-González et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques - Implications for plaque stabilization
M Crisby et al.
CIRCULATION (2001)
Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering
SH Wilson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Effects of the new hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on anti-oxidant enzyme activities and renal function in streptozotocin-induced diabetic rats
A Kurusu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2000)
LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells -: Involvement of S-adenosylmethionine-dependent methyltransferases
RH Böger et al.
CIRCULATION RESEARCH (2000)
Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect -: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cells
I Inoue et al.
LIFE SCIENCES (2000)
Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae
H Kothe et al.
CIRCULATION (2000)
Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
J Al Suwaidi et al.
CIRCULATION (2000)
Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
AH Wagner et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
